Walmart join MediLedger medical supply chain blockchain network
pharmafile | June 3, 2019 | News story | Manufacturing and Production | MediLedger, blockchain, medical supply chain, pharma
Walmart has joined the MediLedger network – a network of pharma firms who use a permissioned blockchain to manage the distribution of medical supplies.
The retail giant, who already use IBM’s blockchain network FoodTrust, has now joined the permissioned blockchain network MediLedger, whose members include Genentech, Pfizer and Gilead.
Walmart will use the MediLedger blockchain to improve their business selling healthcare products and medical supplies, a section of their business which accounted for $35 billion in revenue in the last financial year.
Based on Ethereum the MediLedger blockchain keeps an unchangeable record of transactions on a permissioned ledger.
MediLedger itself has set the bar high as it aims to create “an industry-wide network owned by the industry itself, connecting you to all your suppliers and customers.” The project was started in 2017.
Louis Goss
Related Content
FDA approves IMIDEX’s AI-powered device VisiRad XR
The technological pharmaceutical company IMIDEX has been granted clearance from the US Food and Drug …
Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo
On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ …
Novartis acquires Chinook Therapeutics for $3.5bn
Swiss pharmaceutical company Novartis has entered into an agreement and plan of merger with US-based …